Biofrontera (BFRI) has provided an update.
Biofrontera Inc. has announced the release of its new FDA-approved product, the RhodoLED® XL, a cutting-edge red light emitting LED lamp, which is expected to make a significant impact in the market. This development could be of great interest to investors and stock market watchers, as it represents a potential growth opportunity for the company’s portfolio.
For detailed information about BFRI stock, go to TipRanks’ Stock Analysis page.
